CRISPR-Cas9?based lipid nanocarriers for advanced therapy of urinary bladder cancer. Mukherjee S, Karati D, Sarkar S, Ash D, et al. Nanomedicine (Lond) 2026 Sep 10:1-11. doi: 10.1080/17435889.2026.2732014.

Read + Share

Amedeo Smart

Independent Medical Education

Mukherjee S, Karati D, Sarkar S, Ash D, et al. CRISPR-Cas9?based lipid nanocarriers for advanced therapy of urinary bladder cancer. Nanomedicine (Lond) 2026 Sep 10:1-11. doi: 10.1080/17435889.2026.2732014.
PMID: 42720610